Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2014-10-31
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Functional MRT enables imaging of activated brain regions, either without ("resting state") or with specific stimuli. The investigators speculate that there is a specific involvement of the insula region during TTC.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain MRI in Stroke Patients With Intracardiac Thrombus
NCT04456309
The Brain Heart Interaction in Acute Stroke
NCT02734082
Atrial Fibrillation as a Cause of Stroke and Intracranial Hemorrhage Study (The FibStroke Study)
NCT02146040
Carotid Plaque Imaging in Acute Stroke
NCT01284933
Diagnosis by Comprehensive Cardiovascular Imaging for Stroke and TIA
NCT03618069
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TTC
postmenopausal women with acute Takotsubo cardiomyopathy (TTC), diagnosis by coronary angiography within 24 hours of symptom onset
No interventions assigned to this group
NSTEMI / STEMI
postmenopausal women with acute ST elevation myocardial infarction (NSTEMI / STEMI), diagnosis by coronary angiography within 24 hours of symptom onset
No interventions assigned to this group
healthy subjects
healthy postmenopausal women without coronary artery disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed written consent
* TTC or NSTEMI / STEMI undergoing coronary angiography within 24 hours of symptom onset
Exclusion Criteria
* Inability to perform rsfMRT within the first 72 hours after coronary angiography
* Inability to communicate in German language
* Contraindications for a MRT examination (including pacemaker, implantable cardioverter-defibrillator, mechanical heart valves, claustrophobia, severe adipositas)
* Drug addiction, under guardianship
* Inability to stick to the follow up examination
90 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wolfgang Dichtl, MD PhD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wolfgang Dichtl, MD PhD
Priv.Doz. DDr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wolfgang Dichtl, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Medical University Innsbruck
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University Innsbruck
Innsbruck, Tyrol, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TAKINSULA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.